SUSMED,Inc.

Tokyo Stock Exchange 4263.T

SUSMED,Inc. Capital Expenditure for the year ending June 30, 2024: USD -57.76 K

SUSMED,Inc. Capital Expenditure is USD -57.76 K for the year ending June 30, 2024, a 54.16% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • SUSMED,Inc. Capital Expenditure for the year ending June 30, 2023 was USD -126.01 K, a -35.68% change year over year.
  • SUSMED,Inc. Capital Expenditure for the year ending June 30, 2022 was USD -92.87 K, a -134.48% change year over year.
  • SUSMED,Inc. Capital Expenditure for the year ending June 30, 2021 was USD -39.61 K, a -1.86% change year over year.
  • SUSMED,Inc. Capital Expenditure for the year ending June 30, 2020 was USD -38.89 K.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
SV Wall Street
Tokyo Stock Exchange: 4263.T

SUSMED,Inc.

CEO Mr. Taro Ueno
IPO Date Dec. 24, 2021
Location Japan
Headquarters MFPR Nihonbashi honcho Bldg
Employees 39
Sector Health Care
Industries
Pharmaceuticals Mobile Apps Smartphones
Description

SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

StockViz Staff

February 1, 2025

Any question? Send us an email